← All CTR Flashcard Decks

Casefinding Flashcards

6 cards from real CTR practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 Casefinding flashcards as text
  1. What is the primary goal of casefinding in a cancer registry?

    Answer: To identify reportable cancer cases

    Casefinding is the systematic process employed by cancer registries to identify all eligible cases of cancer within a defined population or institution. Its primary goal is to ensure comprehensive and accurate data collection by finding every new cancer diagnosis that meets the registry's reporting criteria. This ensures a complete record of all reportable cases for statistical analysis and public health monitoring.

  2. Which of the following sources is MOST commonly used for casefinding?

    Answer: Pathology reports

    Pathology reports are considered the most definitive and commonly used source for cancer casefinding because they provide a confirmed diagnosis of malignancy. These reports contain crucial information such as tumor type, grade, and site, which are essential for determining reportability and for abstracting data into the registry. While other sources can be helpful, pathology reports offer direct evidence of cancer.

  3. Why is it important to use multiple sources for casefinding?

    Answer: To identify all reportable cases

    Using multiple sources for casefinding is crucial to ensure that no reportable cancer cases are missed. Relying on a single source might lead to incomplete data, as different departments or systems may capture varying aspects of a patient's journey. By cross-referencing information from various sources like pathology, radiology, and discharge records, registries can achieve comprehensive identification of all eligible cancer cases, ensuring data completeness and accuracy.

  4. Which coding system is typically used to determine if a case is reportable?

    Answer: ICD-O-3

    The International Classification of Diseases for Oncology, Third Edition (ICD-O-3) is the standard coding system specifically used by cancer registries to classify the topography (site) and morphology (histology/behavior) of neoplasms. This system is essential for determining if a case meets the criteria for reportability to the cancer registry. While ICD-10-CM is used for general medical diagnoses, ICD-O-3 is specialized for cancer coding and reportability.

  5. What type of cancer case may be EXCLUDED during casefinding?

    Answer: Benign neoplasm of the skin

    Cancer registries typically focus on malignant and certain in situ neoplasms, which are cancerous or pre-cancerous conditions. Benign neoplasms, by definition, are non-cancerous and do not spread to other parts of the body. Therefore, a benign neoplasm of the skin would generally be excluded during casefinding, as it does not meet the criteria for a reportable cancer case.

  6. How often should casefinding be performed in a hospital-based registry?

    Answer: Weekly or monthly

    Casefinding should be performed regularly and frequently, typically on a weekly or monthly basis, in a hospital-based cancer registry. This consistent schedule ensures that new cancer diagnoses are identified promptly, preventing backlogs and allowing for timely data abstraction. Regular casefinding also helps maintain the accuracy and completeness of the registry data by capturing cases as they are diagnosed.

How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. ncra-usa.org — Renewal, eligibility, passing score, retake policy, score release, test dates, time limit, test delivery, fees, registration deadline · verified Oct 2026